LATEST PRESS RELEASES

FEBRUARY 29, 2024

IRLAB to present at Life Science-dagen in Gothenburg and have a fireside chat with ABG

Gothenburg, Sweden, February 29, 2024 – IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson’s disease, today announced that the company will present at the event Life Science-dagen in Gothenburg on March 6. The company will also participate in a fireside chat with ABG, to be published on March 6.

Read More >
FEBRUARY 28, 2024

IRLAB to present at the Bayes@Lund 2024 Conference in Lund, Sweden on March 7

Read More >
FEBRUARY 27, 2024

IRLAB to present clinical and preclinical data at the AD/PD™ 2024: 18th International Conference on Alzheimer’s & Parkinson’s Diseases

Read More >
EVENT CALENDAR

FINANCIAL CALENDAR

NEXT

week 18 (April 29-May 3)

Annual report

FOLLOWING

May 8, 2024

Interim report January-March 2024